District de Basse-Franconie And NotNinette Amariglio
List of bibliographic references
Number of relevant bibliographic references: 17.Ident. | Authors (with country if any) | Title |
---|---|---|
001446 | M. Macht [Allemagne] ; R. Schwarz [Allemagne] ; H. Ellgring [Allemagne] | Patterns of psychological problems in Parkinson's disease |
001504 | Charlotte Meindorfner [Allemagne] ; Yvonne Körner [Allemagne] ; Jens Carsten Möller [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Wolfgang Hermann Oertel [Allemagne] ; Hans-Peter Krüger [Allemagne] | Driving in Parkinson's disease: Mobility, accidents, and sudden onset of sleep at the wheel |
001896 | J. Carsten Möller [Allemagne] ; Karin Stiasny [Allemagne] ; Volker Hargutt [Allemagne] ; Werner Cassel [Allemagne] ; Heiko Tietze [Allemagne] ; J. Hermann Peter [Allemagne] ; H. Eter Krüger [Allemagne] ; Wolfgang H. Oertel [Allemagne] | Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: A pilot study |
001C22 | Nuria Durany [Espagne, Allemagne, États-Unis] ; Robert Zöchling [Allemagne] ; Karl W. Boissl [Allemagne] ; Werner Paulus [Allemagne] ; Gerhard Ransmayr [Autriche] ; Thomas Tatschner [Allemagne] ; Walter Danielczyk [Autriche] ; Kurt Jellinger [Autriche] ; Jürgen Deckert [Allemagne] ; Peter Riederer [Allemagne] | Human post-mortem striatal α4β2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome |
001C47 | G. Münch [Allemagne] ; H. J. Lüth [Allemagne] ; A. Wong [Allemagne] ; Th. Arendt [Allemagne] ; E. Hirsch [France] ; R. Ravid [Pays-Bas] ; P. Riederer [Allemagne] | Crosslinking of α-synuclein by advanced glycation endproducts — an early pathophysiological step in Lewy body formation? |
001D77 | Rejko Krüger [Allemagne] ; Ana Maria Menezes Vieira-Saecker [Allemagne] ; Wilfried Kuhn [Allemagne] ; Daniela Berg [Allemagne] ; Thomas Müller [Allemagne] ; Natalia Kühnl [Allemagne] ; Gerd A. Fuchs [Allemagne] ; Alexander Storch [Allemagne] ; Marcel Hungs [Allemagne] ; Dirk Woitalla [Allemagne] ; Horst Przuntek [Allemagne] ; Jörg T. Epplen [Allemagne] ; Ludger Schöls [Allemagne] ; Olaf Riess [Allemagne] | Increased susceptibility to sporadic Parkinson's disease by a certain combined α‐synuclein/apolipoprotein E genotype |
001F60 | Klaus W. Lange [Allemagne] ; Johannes Kornhuber [Allemagne] ; Peter Riederer [Allemagne] | Dopamine/glutamate interactions in Parkinson's disease |
001F89 | Marcia C. Smith [Royaume-Uni] ; Heiner Ellgring [Allemagne] ; Wolfgang H. Oertel [Allemagne] | Sleep Disturbances in Parkinson's Disease Patients and Spouses |
002134 | M. Gerlach [Allemagne] ; W. Kuhn ; Th. Müller ; P. Klotz ; H. Przuntek | Sustained-release of levodopa: single dose study of a new formulation |
002212 | Manfred Gerlach [Allemagne] ; Wieland Gsell [Allemagne] ; Johannes Kornhuber [Allemagne] ; Kurt Jellinger [Autriche] ; Verena Krieger [Autriche] ; Felix Pantucek [Autriche] ; Reinhard Vock [Allemagne] ; Peter Riederer [Allemagne] | A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome |
002544 | J. Kornhuber [Allemagne] ; M. Weller [Allemagne] ; P. Riederer [Allemagne] | Glutamate receptor antagonists for neuroleptic malignant syndrome and akitetic hyperthermic Parkinsonian crisis |
002547 | D. Zillikens [Allemagne] ; A. Ambach [Allemagne] ; A. Zentner [Allemagne] ; R. Dummer [Suisse] ; M. Schüssler [Allemagne] ; G. Burg [Suisse] ; E. B. Bröcker [Allemagne] | Evidence for cell‐mediated immune mechanisms in the pathology of pemphigus |
002552 | H. Youdim [Israël] ; P. Riederer [Allemagne] | Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition |
002644 | H. Przuntek [Allemagne] ; D. Welzel [Allemagne] ; E. Blümner [Allemagne] ; W. Danielczyk [Autriche] ; H. Letzel [Allemagne] ; -J. Kaiser [Allemagne] ; H. Kraus [Allemagne] ; P. Riederer [Allemagne] ; D. Schwarzmann [Allemagne] ; H. Wolf [Allemagne] ; K. Überla [Allemagne] | Bromocriptine lessens the incidence of mortality in L-Dopa-treated parkinsonian patients: Prado-study discontinued |
002787 | K. Jellinger [Autriche] ; W. Paulus [Autriche] ; I. Grundke-Iqbal [États-Unis] ; P. Riederer [Allemagne] ; H. Youdim [Israël] | Brain iron and ferritin in Parkinson's and Alzheimer's diseases |
002877 | E. Sofic [Allemagne] ; P. Riederer [Allemagne] ; H. Heinsen [Allemagne] ; H. Beckmann [Allemagne] ; P. Reynolds [Royaume-Uni] ; G. Hebenstreit [Autriche] ; H. Youdim [Israël] | Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain |
002987 | H. Przuntek [Allemagne] ; H. Ru [Allemagne] ; K. Henning [Allemagne] ; U. Pindur [Allemagne] | The protective effect of 1-tert.butyl-4,4-diphenylpiperidine against the nigrostriatal neurodegeneration caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
This area was generated with Dilib version V0.6.23. |